The body composition point is one of the most underappreciated aspects of these medications. Two people at the same scale weight can look completely different and have very different metabolic risk profiles based on muscle versus fat distribution. GLP-1, when combined with adequate protein intake, can shift that ratio meaningfully even when the scale slows. For people with high visceral fat burden, inflammation and glucose improvements often show up before dramatic scale changes. The emotional eating component matters here too - quieting the reward circuitry affects more than just food obsession, and for people with complicated eating histories, it can open space that wasn't there before.